Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne
Multicentric, Parallel, Randomized, Double Blind Study Under Dermatological Control to Evaluate the Anti-acne Efficacy of a Dermo-cosmetic Product (Fla 688977 33) Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer (Hydréane légère, Cosmétique Active International) During a 12-week Application Period in Male and Female Subjects Presenting With Mild to Moderate Acne
Sponsor: Vichy Laboratoires
This PHASE4 trial investigates Acne and is currently completed. Vichy Laboratoires leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2021 — Nov 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE4
▶ Show 1 earlier version
-
Mar 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vichy Laboratoires
For direct contact, visit the study record on ClinicalTrials.gov .